Jump to content

Center for Biologics Evaluation and Research: Difference between revisions

Line 80: Line 80:
* [[Cardiovascular and Renal Drugs Advisory Committee]]
* [[Cardiovascular and Renal Drugs Advisory Committee]]
* [[Cellular, Tissue, and Gene Therapies Advisory Committee]]
* [[Cellular, Tissue, and Gene Therapies Advisory Committee]]
* [[[[Dermatologic and Ophthalmic Drugs Advisory Committee]] ]] (DODAC)
* [[Dermatologic and Ophthalmic Drugs Advisory Committee]] (DODAC)
* [[Device Good Manufacturing Practice Advisory Committee]] (DGMPAC)
* [[Device Good Manufacturing Practice Advisory Committee]] (DGMPAC)
* [[Drug Safety and Risk Management Advisory Committee]
* [[Drug Safety and Risk Management Advisory Committee]